DaVita
DVA
#1533
Rank
โ‚ฌ12.59 B
Marketcap
196,19ย โ‚ฌ
Share price
0.45%
Change (1 day)
62.59%
Change (1 year)
DaVita Inc. is an American company providing dialysis services for patients with chronic and acute kidney failure.

EPS for DaVita (DVA)

EPS in 2026 (TTM): 9,40ย โ‚ฌ

According to DaVita's latest financial reports the company's current EPS (TTM) is 9,66ย โ‚ฌ. In 2025 the company made an earnings per share (EPS) of 8,88ย โ‚ฌ a decrease over its 2024 EPS that were of 9,68ย โ‚ฌ.

EPS history for DaVita from 2012 to 2026

Annual EPS

Year EPS Change
2026 (TTM)9,40ย โ‚ฌ5.75%
20258,88ย โ‚ฌ-8.25%
20249,68ย โ‚ฌ44.94%
20236,68ย โ‚ฌ27.26%
20225,25ย โ‚ฌ-35.56%
20218,15ย โ‚ฌ44.1%
20205,65ย โ‚ฌ19.7%
20194,72ย โ‚ฌ540.48%
20180,74ย โ‚ฌ-76.07%
20173,08ย โ‚ฌ-19.31%
20163,82ย โ‚ฌ242.52%
20151,11ย โ‚ฌ-62.87%
20143,00ย โ‚ฌ13.43%
20132,65ย โ‚ฌ8.45%
20122,44ย โ‚ฌ

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
Universal Health Services
UHS
21,34ย โ‚ฌ 121.00%๐Ÿ‡บ๐Ÿ‡ธ USA
LabCorp
LH
9,97ย โ‚ฌ 3.27%๐Ÿ‡บ๐Ÿ‡ธ USA
Tenet Healthcare
THC
17,08ย โ‚ฌ 76.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Pediatrix Medical Group
MD
1,69ย โ‚ฌ-82.45%๐Ÿ‡บ๐Ÿ‡ธ USA